A 6-year-old child with β-thalassemia major is being evaluated during a routine clinic visit. Which assessment finding would be most concerning and require immediate intervention?
The nurse is assessing a pediatric patient with β-thalassemia major who receives regular blood transfusions.
1Serum ferritin level of 4,500 ng/mL✓ 정답
2Hemoglobin level of 8.5 g/dL
3Mild splenomegaly on palpation
4Fatigue during moderate physical activity
해설
Serum ferritin level of 4,500 ng/mL indicates severe iron overload, which is a life-threatening complication requiring immediate chelation therapy to prevent organ damage.
Core Nursing ExplanationKey Concept Analysis: This question assesses the nurse's ability to identify a life-threatening complication in a child with β-thalassemia major. The core pathophysiology involves chronic anemia requiring regular blood transfusions. While transfusions correct the anemia, each unit of packed red blood cells (PRBCs) introduces a significant iron load. The body has no active mechanism to excrete this excess iron, leading to iron overload (hemosiderosis). Over time, iron deposits in vital organs (heart, liver, endocrine glands) cause organ dysfunction and failure, which is the leading cause of death in these patients.
Answer Rationale: Key Point!Serum ferritin level of 4,500 ng/mL is critically high. Serum ferritin is the primary marker for monitoring total body iron stores. A level this elevated indicates severe, potentially life-threatening iron overload requiring immediate intervention with iron chelation therapy (e.g., deferoxamine, deferasirox). Without prompt treatment, the risk for cardiac arrhythmias, congestive heart failure, and liver cirrhosis is imminent.
Distractor Analysis:
Hemoglobin level of 8.5 g/dL: While below the normal pediatric range (~11-14 g/dL), this is a typical Watch out for confusion!expected finding for a patient with thalassemia major between transfusions. The goal of transfusion therapy is often to maintain Hb above 9-10 g/dL to suppress ineffective erythropoiesis, so 8.5 g/dL might prompt scheduling the next transfusion but is not an immediate crisis.
Mild splenomegaly on palpation: This is a common chronic complication due to extramedullary hematopoiesis and RBC sequestration. It requires monitoring but is not an acute, life-threatening finding.
Fatigue during moderate physical activity: This is a direct consequence of chronic anemia and is an expected symptom. It indicates the need for activity pacing and education but does not signal an immediate danger.
Related Concepts: Nurses must understand the balance in managing thalassemia: treating the anemia with transfusions while aggressively preventing the complication of iron overload. Patient and family education on strict adherence to chelation therapy is a cornerstone of long-term care.
Concept Summary
Concept
Description
Nursing Implication
β-Thalassemia Major
Genetic disorder causing deficient β-globin chain synthesis, leading to severe hemolytic anemia.
Lifelong management with transfusions and iron chelation.
Iron Overload (Transfusional Hemosiderosis)
Accumulation of iron in tissues (heart, liver, endocrine) from chronic transfusions.
Monitor serum ferritin. Educate on chelation therapy adherence.
Iron Chelation Therapy
Drugs that bind excess iron for excretion (Deferoxamine IV/SC, Deferasirox oral).
Administer as ordered. Monitor for side effects (auditory/visual, renal, GI).
Splenomegaly
Enlarged spleen from extramedullary hematopoiesis and RBC destruction.
Palpate gently. Teach patient to avoid contact sports. Monitor for hypersplenism.
Side-by-Side Comparison!
Assessment Finding
In β-Thalassemia Major
Level of Urgency
Rationale
High Serum Ferritin (>2,500 ng/mL)
Sign of iron overload
HIGH - Requires immediate intervention
Prevents fatal organ damage (cardiac, hepatic).
Low Hemoglobin (e.g., 8.5 g/dL)
Sign of anemia
Moderate - Requires planned intervention
Expected chronic state; schedule next transfusion.
Splenomegaly
Sign of chronic disease progression
Low - Requires monitoring
Chronic complication; risk for rupture if severe.
Anatomy, Physiology & Pharmacology Points
Pathophysiology: Defective β-globin genes → reduced hemoglobin A → severe microcytic, hypochromic anemia → compensatory bone marrow expansion and extramedullary hematopoiesis.
Iron Metabolism: Each unit of PRBCs contains ~200-250 mg of iron. The body excretes only 1-2 mg/day. Without chelation, iron accumulates at a rate of ~0.5 mg/kg/day from transfusions.
Pharmacology - Chelators: Deferoxamine binds iron; administered via slow subcutaneous infusion over 8-12 hours. Deferasirox is an oral chelator; take on an empty stomach 30 min before food, monitor renal/hepatic function.
Memory Tips
FERITIN = FE (Iron) STORED IN the body. High ferritin = High stored iron = High danger.
The Iron Triad of Thalassemia Care: Transfuse (for anemia) → Chelate (for iron) → Monitor (for complications).
High-Frequency NCLEX Topics
NCLEX loves to test complication recognition and priority setting. For chronic conditions requiring ongoing treatment (like thalassemia, hemodialysis), the acute, life-threatening complication of the therapy itself (iron overload, electrolyte imbalance) is often the correct answer over the chronic symptoms of the disease.
Watch Out for Question Variations!
Shift from Assessment to Intervention: "The nurse notes a serum ferritin of 4,500 ng/mL in a child with thalassemia. Which action should the nurse take first?" (Answer: Notify the healthcare provider to discuss/initiate chelation therapy).
Shift to Patient Education: "Which statement by the parent of a child with thalassemia indicates understanding of iron chelation therapy?" (Correct: "I will make sure my child takes the deferasirox on an empty stomach every day.")
Lab Value Interpretation: They may give you a list of labs (Hb, Hct, ferritin, liver enzymes) and ask which is most critical to address.
Nursing Clinical Practice GuideClinical Scenario: You are a clinic nurse. Jason, a 7-year-old with β-thalassemia major, comes for his monthly check-up. He receives PRBC transfusions every 3-4 weeks. His mother reports he's been more tired lately but is otherwise playful. His vital signs are stable.
Nursing Intervention Strategy:
Assessment: Review all recent lab work, with immediate focus on the serum ferritin level. Perform a thorough physical assessment, noting skin color (looking for bronze/gray hue of hemochromatosis), listening for signs of heart failure (gallop rhythm, crackles), and palpating the abdomen for hepatosplenomegaly.
Nursing Diagnosis: Risk for decreased cardiac output related to myocardial iron deposition. Risk for ineffective health management related to complexity of lifelong treatment regimen.
Planning & Implementation:
If ferritin is severely elevated (>2,500 ng/mL), immediately notify the pediatric hematologist or advanced practice provider. This is a priority communication.
Reinforce education about the absolute necessity of adherence to chelation therapy. Demonstrate proper technique for subcutaneous deferoxamine pump setup if used.
Coordinate care: Schedule appointments with cardiology (for echocardiograms), endocrinology (for monitoring growth and glucose - iron damages the pancreas), and hepatology.
Patient Safety and Precautions:
Transfusion Safety: Meticulous blood product administration following protocols to prevent transfusion reactions.
Medication Safety: Chelators have significant side effects. Deferoxamine can cause ototoxicity and visual disturbances; require regular audiometric and ophthalmologic exams. Deferasirox can cause GI upset and renal impairment; monitor BUN/Creatinine.
Infection Risk: Patients who have had splenectomies are at high risk for overwhelming post-splenectomy infection (OPSI). Ensure they are up-to-date on vaccinations (Pneumococcal, Hib, Meningococcal, annual influenza) and educate parents to seek immediate care for any fever.
Nursing Procedure & Medication FlowManaging Iron Chelation Therapy:
Step
Action
Rationale & Key Points
1. Assessment
Check most recent serum ferritin, creatinine, ALT/AST, and auditory/visual exam results.
Determines therapy efficacy and screens for toxicity before administration.
2. Preparation (Deferoxamine SC)
Reconstitute powder with sterile water. Draw up into syringe and connect to a portable infusion pump and small-gauge subcutaneous needle.
Typically infused over 8-12 hours, often overnight. Rotate injection sites (abdomen, thighs) to prevent lipodystrophy.
3. Education (Deferasirox Oral)
Instruct to take tablet on an empty stomach, at least 30 minutes before food, preferably at the same time each day. Tablet should be dispersed in water/orange juice/apple juice.
Food significantly reduces absorption. Consistent timing maintains steady drug levels.
4. Monitoring & Evaluation
Schedule regular lab draws (ferritin monthly, renal/hepatic function quarterly). Ask about adherence and any side effects (nausea, diarrhea, hearing changes).
Goal is to reduce and maintain serum ferritin < 1,000 ng/mL. Evaluate therapeutic effectiveness and patient tolerance.
A Word from Your Senior Nurse
Caring for a child with a lifelong condition like thalassemia is about partnership. You're not just treating a disease; you're supporting a child and a family through a complex journey. That sky-high ferritin level isn't just a number on a page—it's a ticking clock for that child's heart and liver. Your vigilance in monitoring and your skill in educating the family about the why behind every pill and every pump are what turn a chronic diagnosis into a manageable life. On the NCLEX and at the bedside, always look for the complication of the treatment—it's often the silent priority that needs your immediate attention.
β-thalassemia major — A severe genetic hemoglobinopathy characterized by deficient synthesis of β-globin chains, leading to profound anemia, ineffective erythropoiesis, and dependence on lifelong regular blood transfusions for survival.
Transfusional iron overload — The pathological accumulation of iron in body tissues (especially heart, liver, endocrine glands) as a consequence of chronic red blood cell transfusions, which is the leading cause of morbidity and mortality in transfusion-dependent patients.
Serum ferritin — A blood test that serves as the primary clinical marker for estimating total body iron stores. In thalassemia, levels >1,000 ng/mL indicate iron overload, and levels >2,500 ng/mL signify severe overload requiring urgent intervention.
Iron chelation therapy — Pharmacological treatment using agents (e.g., deferoxamine, deferasirox, deferiprone) that bind excess iron to form complexes that can be excreted from the body, preventing organ damage from transfusional iron overload.
Splenomegaly — Enlargement of the spleen, commonly seen in thalassemia due to extramedullary hematopoiesis and sequestration of abnormal red blood cells. It can lead to hypersplenism (increased destruction of blood cells) and is a risk factor for splenic rupture.